Xxxxxxxx-Xxxxx; Disclosure Controls. The Company is in compliance in all material respects with the applicable provisions of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations promulgated thereunder. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) that comply with the requirements of the Exchange Act. Such disclosure controls and procedures have been designed to ensure that material information relating to the Company and its Subsidiaries is made known to the Company’s principal executive officer and principal financial officer by others within those entities, and such disclosure controls and procedures are effective in all material respects. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”) and nothing has occurred since the Evaluation Date that has materially impacted the effectiveness of such disclosure controls and procedures.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Monopar Therapeutics), Securities Purchase Agreement (Shattuck Labs, Inc.), Securities Purchase Agreement (Viridian Therapeutics, Inc.\DE)